Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Revenue

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹3,454 Cr₹3,252 Cr₹3,278 Cr₹2,926 Cr₹3,224 Cr

What is the latest Revenue of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Revenue ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹3,454 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹3,454 Cr
Mar2024₹3,252 Cr
Mar2023₹3,278 Cr
Mar2022₹2,926 Cr
Mar2021₹3,224 Cr

How is Revenue of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹3,454 Cr
6.21
Mar2024 ₹3,252 Cr
-0.80
Mar2023 ₹3,278 Cr
12.05
Mar2022 ₹2,926 Cr
-9.27
Mar2021 ₹3,224 Cr -

Compare Revenue of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹53,441.5 Cr 1.2% -4.3% 17.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

1.2%

-4.3%

17.3%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses